<DOC>
	<DOCNO>NCT01365403</DOCNO>
	<brief_summary>This open-label , fixed sequence , two-period study assess effect multiple dose carbamazepine single dose pharmacokinetics RO4917838 . Subjects receive single oral dose RO4917838 Day 1 12-day study period 1 , washout 3-6 week , study period 2 carbamazepine orally daily Days 1-24 single oral dose RO4917838 Day 16 .</brief_summary>
	<brief_title>A Study The Effect Multiple Dose Carbamazepine Single Dose Pharmacokinetics RO4917838 Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Carbamazepine</mesh_term>
	<criteria>Adult healthy male volunteer , 1865 year age inclusive Body mass index ( BMI ) 1830 kg/m2 inclusive History presence disorder condition would render subject unsuitable study , place subject undue risk interfere ability subject complete study opinion investigator History significant cardiovascular , hepatic , renal , respiratory , gastrointestinal , endocrine , immunologic , allergic , dermatologic , hematologic , neurologic psychiatric disease , cancer Any confirm significant allergic reaction drug , multiple allergy judgment investigator Native Asians subject Asian racial origin</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>